Related Experiment Video
Updated: Jul 16, 2025

Immunophenotyping of Orthotopic Homograft Syngeneic of Murine Primary KPC Pancreatic Ductal Adenocarcinoma by Flow Cytometry
Published on: October 9, 2018
High risk clear cell renal cell carcinoma microenvironments contain protumour immunophenotypes lacking specific
Arti M Raghubar1,2,3,4,5,6, Nicholas A Matigian7, Joanna Crawford5
1Kidney Health Service, Royal Brisbane and Women's Hospital, Herston, QLD, Australia.
Abstract:
Perioperative immune checkpoint inhibitor (ICI) trials for intermediate high-risk clear cell renal cell carcinoma (ccRCC) have failed to consistently demonstrate improved patient outcomes. These unsuccessful ICI trials suggest that the tumour infiltrating immunophenotypes, termed here as the immune cell types, states and their spatial location within the tumour microenvironment (TME), were unfavourable for ICI treatment. Defining the tumour infiltrating immune cells may assist with the identification of predictive immunophenotypes within the TME that are favourable for ICI treatment. To define the immunophenotypes within the ccRCC TME, fresh para-tumour (pTME, n = 2), low-grade (LG, n = 4, G1-G2) and high-grade (HG, n = 4, G3-G4) tissue samples from six patients with ccRCC presenting at a tertiary referral hospital underwent spatial transcriptomics sequencing (ST-seq). Within the generated ST-seq datasets, immune cell types and states, termed here as exhausted/pro-tumour state or non-exhausted/anti-tumour state, were identified using multiple publicly available single-cell RNA and T-cell receptor sequencing datasets as references. HG TMEs revealed abundant exhausted/pro-tumour immune cells with no consistent increase in expression of PD-1, PD-L1 and CTLA4 checkpoints and angiogenic genes. Additional HG TME immunophenotype characteristics included: pro-tumour tissue-resident monocytes with consistently increased expression of HAVCR2 and LAG3 checkpoints; an exhausted CD8+ T cells sub-population with stem-like progenitor gene expression; and pro-tumour tumour-associated macrophages and monocytes within the recurrent TME with the expression of TREM2. Whilst limited by a modest sample size, this study represents the largest ST-seq dataset on human ccRCC. Our study reveals that high-risk ccRCC TMEs are infiltrated by exhausted/pro-tumour immunophenotypes lacking specific checkpoint gene expression confirming that HG ccRCC TME are immunogenic but not ICI favourable.
Insights
High-risk clear cell renal cell carcinoma (ccRCC) tumors have exhausted immune cells unfavorable for immunotherapy. Spatial transcriptomics reveals these tumors are immunogenic but not responsive to immune checkpoint inhibitors (ICIs).
Area of Science:
- Oncology
- Immunology
- Genomics
Background:
- Perioperative immune checkpoint inhibitor (ICI) trials for high-risk clear cell renal cell carcinoma (ccRCC) have yielded inconsistent patient outcomes.
- This suggests that the tumor microenvironment (TME) immune cell composition and spatial organization may be unfavorable for ICI therapy.
Purpose of the Study:
- To define the immunophenotypes within the ccRCC TME using spatial transcriptomics.
- To identify predictive immune cell signatures associated with treatment response in ccRCC.
Main Methods:
- Spatial transcriptomics sequencing (ST-seq) was performed on fresh para-tumour (pTME), low-grade (LG), and high-grade (HG) ccRCC tissue samples.
- Immune cell types and states (exhausted/pro-tumour vs. non-exhausted/anti-tumour) were identified using reference single-cell RNA and T-cell receptor sequencing datasets.
Main Results:
- High-grade ccRCC TMEs exhibit abundant exhausted/pro-tumour immune cells without increased expression of common checkpoints (PD-1, PD-L1, CTLA4) or angiogenic genes.
- Distinct HG TME features include pro-tumour monocytes expressing HAVCR2 and LAG3, exhausted CD8+ T cells with stem-like progenitor gene expression, and pro-tumour macrophages/monocytes expressing TREM2.
Conclusions:
- This study provides the largest ST-seq dataset for human ccRCC, revealing exhausted/pro-tumour immunophenotypes in high-risk ccRCC TMEs.
- Despite being immunogenic, HG ccRCC TMEs are characterized by immune cell states that are not favorable for immune checkpoint inhibitor treatment.
More Related Videos
05:36Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane
Published on: February 8, 2020
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
Related Concept Videos
The Tumor Microenvironment
Tumor Immunotherapy